Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00298246 · ClinicalTrials.gov registry record
Clinical and Immunological Investigations of Subtypes of Autism
A clinical trial, sponsored by National Institute of Mental Health (NIMH).
- Completed
- Registry status
- 557
- Enrollment target
NCT00298246: Completed study, sponsored by National Institute of Mental Health (NIMH).
NCT00298246 is a clinical trial that has completed, run by National Institute of Mental Health (NIMH). The registered enrollment target is 557 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00298246 has completed, sponsored by National Institute of Mental Health (NIMH).
- COMPLETED
- Registry status
- 557 participants
- Enrollment target
Study Summary
The purpose of this study is to learn more about autism and its subtypes. Autism is a developmental disorder in which children have problems with communication and social skills and display restricted interests and repetitive behaviors. This study has several goals. One aim is to look at types of autism that are known, such as the regressive subtype, (where skills are lost). We will explore whether there is a unique change in immune functioning related to this subtype. Another aim is to serve as one of the sites that will pilot a larger natural history study, entitled Autism Phenome Project. The goal is to further understand autism by identifying other subtypes. We will look at several types of medical issues that may be related to autism, including immunologic problems. Children will be followed over the course of several years. We aim to capture medical problems that may be related to autism as they develop, and study outcomes in areas such as behavior and language, in order to explore known and new subtypes of autism. Normally developing children (aged 1) with autism (age 1, and developmental delays other than autism (age 1), may be eligible for this study. Depending on each child's study group and age, participants may undergo the following tests and procedures: Baseline Visit * Medical and developmental history, physical examination, psychological, cognitive and medical tests to assess symptoms of autism or other developmental disorders, photographs of the child's face, collection of hair, urine and baby teeth samples. If available, hair samples from the baby's first haircut and from the biological mother's hair are also collected. * Overnight electroencephalogram (EEG): A special cap with electrodes is placed on the child's head to measure brain waves (brain electrical activity) while the child sleeps in the hospital overnight. Healthy volunteers do not undergo this procedure. * Magnetic resonance imaging (MRI) scan: The child stays in the scanner, lying
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 557 participants |
| Start Date | 2006-02-22 |
| Est. Completion | 2017-03-15 |
What the finished NCT00298246 record still lists
NCT00298246 is an observational study that tracks outcomes without assigning an intervention. The registered 557 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00298246 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00298246 about?
NCT00298246 is a clinical study titled "Clinical and Immunological Investigations of Subtypes of Autism". The purpose of this study is to learn more about autism and its subtypes. Autism is a developmental disorder in which children have problems with communication and social skills and display restricted interests and repetitive behaviors. This study has several goals. One aim is to look at types of a...
What is the current status of trial NCT00298246?
This trial is currently completed. The enrollment target is 557 participants. The study started on 2006-02-22. Estimated completion is 2017-03-15.
Who is sponsoring clinical trial NCT00298246?
This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05708885 · 557 participants · NA
Striated Esophageal Motor Function Modulation in Health and Disease
- NCT07173751 · 558 participants · Phase 3
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
- NCT06074588 · 556 participants · Phase 3
Sacituzumab Tirumotecan (MK-2870) Versus Chemotherapy in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations or Other Genomic Alterations (MK-2870-004)
- NCT06693622 · 556 participants
Patient Preferences for Barrett's Esophagus and Esophageal Cancer Screening Tests
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI